MannKind Announces Enrollment Goal Completion of INHALE-1 :

MANNKIND ANNOUNCES ENROLLMENT GOAL COMPLETION OF INHALE-1 PEDIATRIC DIABETES TRIAL UTILIZING AFREZZA...

Related Keywords

Lori Laffel , Kevin Kaiserman , Mannkind Corporation , Clinical Development , Exchange Commission , Professor Of Pediatrics At Harvard Medical School , Mannkind Corporation Nasdaq , Linkedin , Affairs For Mannkind Corporation , Facebook , Young Adult Section At Joslin Diabetes Center , Kind Corporation , Young Adult Section , Joslin Diabetes Center , Harvard Medical , Senior Vice President , Medical Affairs , Annual Report , Nasdaq Mnkd , Mannkind ,